Parallax Announces International Medical Supply Chain Agreement for COVID-19 Testing Kits and FDA Registered Suppliers of Personal Protective Equipment (PPE)

Joint Venture Procures from Established Manufacturers with Reliable Supply and Logistics for US Medical Operations

NEW YORK, NY -- March 30, 2020 -- InvestorsHub NewsWire -- Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced its wholly-owned subsidiary, Parallax Diagnostics, Inc., has executed a joint venture agreement with the United States Marine Corps, (“USMC”) veteran-owned and operated SAGICO USA, a medical device technology and supply chain distribution specialist company. The team at SAGICO USA has a long history of obtaining the required U.S. Food and Drug Administration, (“FDA”) clearances and other regulatory approvals that have allowed the distribution of medical products to government hospitals globally and other customers in over 60 countries. SAGICO USA and Parallax Diagnostics have combined forces to provide reliable product procurement directly from international manufacturers building upon our established global manufacturing and diagnostics relationships stemming from our Company’s patented intellectual property. World leading inventories and end-to-end logistics services related to the International Coronavirus, (“COVID-19”) response are now becoming available at the Company’s website www.goodhealthoutcomes.com. 

With today’s announcement, Parallax is offering to procurement managers from both private and government entities the ability to purchase the much needed personal protection equipment, (“PPE”) items from FDA registered manufacturers. Items included on the Parallax online portal include medical masks, invasive and passive ventilators, thermometers, medical protective gowns, face protection, other personal protective equipment and COVID-19 point of care test kits. These PPE items are also available for export to any country. Please refer to the website as more information and items become available and to place orders at www.goodhealthealthoutcomes.com 

Nathaniel Bradley, Parallax Health Sciences, Inc., Chief Technology Officer stated, “the global response to the COVID-19 pandemic has positioned all three of the Parallax divisions under greater demand, our patented FDA cleared diagnostics, our health management from the patented Good Health Outcomes and HIPAA compliant Telehealth mobile platform, and our patented behavioral solutions. Mr. Bradley continued, “our new relationship with Sagico USA will be instrumental in fortifying our operations and identifying the sustainable footholds in the market where we are focusing our efforts.”

About SAGICO USA

At SAGICO USA, we promote the efficiency needed to bridge the divide between cost containment and achieving the primary focus of clinicians. Because patient care should be at the forefront of clinical and medical professionals, not procurement of supplies. Oftentimes at different stages in the supply chain flow, many departments tend to be focused on their own goal. Providers may want to use a specific product because they were trained with it, whereas hospital executives aim to purchase the most affordable quality items. The hospital and facilities procurement services offered at SAGICO USA begins with getting all hospital departments on the same page. This is a key strategy for optimizing healthcare supply chain management. In the era of value-based care, healthcare organizations are focused on reducing redundancies and eliminating waste, but providers also need to work together to effectively reduce costs and boost performance. The team from SAGICO USA promotes efficiency in the healthcare supply chain, so facilities can create substantial cost-reducing opportunities across their organization. At SAGICO USA we strive to ensure all products meet or exceed all regulatory controls. SAGICO USA was founded by special operations capable veterans of the United States Marine Corps (USMC) and is a US Department of Veteran’s Affairs (VA) verified Service Disabled Veteran Owned Small Business (SDVOSB) company. DUNS: 056853514 / CAGE CODE: 84ZW3. Learn more at www.SAGICOUSA.com. 

About Parallax Diagnostics

Parallax Diagnostics is a bio-medical company and wholly-owned subsidiary of Parallax Health Sciences, Inc. Parallax Diagnostics owns a line of 26 FDA approved, Point of Care diagnostic tests on a single platform in the area of infectious disease, cardiac, medical conditions, drugs of abuse, and pregnancy.  Parallax Diagnostics is developing a novel, handheld diagnostic testing system that is simple, rapid and elegant, offering the potential to transform the diagnostic landscape by transitioning critical tests from the centralized lab directly to the hands of the physician or clinicians. Our focus is on tests that detect and/or monitor infectious diseases.

Investor Contact:
Paul Arena
paul@parallaxcare.com
cell 404-915-8449
SOURCE: Parallax Health Sciences, Inc.
 

Parallax Health Sciences (CE) (USOTC:PRLX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Parallax Health Sciences (CE) (USOTC:PRLX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024